The impact of intratumoral heterogeneity on the prognosis of ER-positive/HER2-negative breast cancer

被引：0
|
作者：
Oikawa, Masahiro
Ishida, Mayumi
Nakamura, Yoshiaki
Nishimura, Sumiko
Koga, Chinami
Saruwatari, Akihiro
Igawa, Akiko
Akiyoshi, Sayuri
Koi, Yumiko
Ohno, Shinji
机构：
[1] Kyushu Natl Canc Ctr, Dept Breast Oncol, Fukuoka, Japan
[2] Kyushu Natl Canc Ctr, Dept Clin Oncol, Fukuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
563
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer
    Richard Buus
    Belinda Yeo
    Adam R. Brentnall
    Marie Klintman
    Maggie Chon U. Cheang
    Komel Khabra
    Ivana Sestak
    Qiong Gao
    Jack Cuzick
    Mitch Dowsett
    [J]. Breast Cancer Research, 20
  • [42] Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer
    Rigter, L. S.
    Loo, C. E.
    Linn, S. C.
    Sonke, G. S.
    van Werkhoven, E.
    Lips, E. H.
    Warnars, H. A.
    Doll, P. K.
    Bruining, A.
    Mandjes, I. A.
    Peeters, M. J. Vrancken
    Wesseling, J.
    Gilhuijs, K. G.
    Rodenhuis, S.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 109 (12) : 2965 - 2972
  • [43] Tackling endocrine resistance in ER-positive HER2-negative advanced breast cancer: A tale of imprecision medicine
    Matikas, Alexios
    Foukakis, Theodoros
    Bergh, Jonas
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 114 : 91 - 101
  • [44] Liquid Biopsy Testing in a Greek Cohort of ER-positive, HER2-negative metastatic breast cancer patients
    Tsoulos, Nikolaos
    Meintani, Angeliki
    Kapetsis, Georgios
    Chatzigiannidou-Florou, Chrysiis
    Tsantikidi, Aikaterini
    Maxouri, Stella
    Thanou, Eleni
    Aggelaina, Kalliopi
    Metaxa-Mariatou, Vasiliki
    Tsaousis, Georgios
    Natsiopoulos, Ioannis
    Venizelos, Vasileios
    Markopoulos, Christos
    Zagouri, Flora
    Kampletsas, Eleftherios
    Karyda, Eirini
    Tryfonopoulos, Dimitrios
    Papazisis, Konstantinos
    Ziogas, Dimitrios
    Athanasiadis, Ilias
    Papadopoulou, Eirini
    Nasioulas, Georgios
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [45] Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer
    Buus, Richard
    Yeo, Belinda
    Brentnall, Adam R.
    Klintman, Marie
    Cheang, Maggie Chon U.
    Khabra, Komel
    Sestak, Ivana
    Gao, Qiong
    Cuzick, Jack
    Dowsett, Mitch
    [J]. BREAST CANCER RESEARCH, 2018, 20
  • [46] A predictor model for pathological CR after neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer
    Fujiki, Yoshitaka
    Yamamoto, Yutaka
    Tomiguchi, Mai
    Sueta, Aiko
    Takeshita, Takashi
    Ibusuki, Mutsuko
    Iwase, Hirotaka
    [J]. CANCER SCIENCE, 2018, 109 : 654 - 654
  • [47] Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer
    Pelaez-Garcia, Alberto
    Yebenes, Laura
    Berjon, Alberto
    Angulo, Antonia
    Zamora, Pilar
    Sanchez-Mendez, Jose Ignacio
    Espinosa, Enrique
    Redondo, Andres
    Heredia-Soto, Victoria
    Mendiola, Marta
    Feliu, Jaime
    Hardisson, David
    [J]. PLOS ONE, 2017, 12 (09):
  • [48] Anthracycline-free Neo-adjuvant Treatment for Patients with ER-positive, HER2-negative Breast Cancer
    Lorenz, Judith
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (03) : 248 - 248
  • [49] Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer
    Constantinidou, Anastasia
    Marcou, Yiola
    Toss, Michael S.
    Simmons, Timothy
    Bernhisel, Ryan
    Hughes, Elisha
    Probst, Braden
    Meek, Stephanie
    Kakouri, Eleni
    Georgiou, Georgios
    Zouvani, Ioanna
    Savvidou, Gabriella
    Kuhl, Vanessa
    Doedt, Jennifer
    Wagner, Susanne
    Gutin, Alexander
    Slavin, Thomas P.
    Lanchbury, Jerry S.
    Kronenwett, Ralf
    Ellas, Ian O.
    Rakha, Emad A.
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (20) : 4435 - 4443
  • [50] Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer
    Loo, Claudette E.
    Rigter, Lisanne S.
    Pengel, Kenneth E.
    Wesseling, Jelle
    Rodenhuis, Sjoerd
    Peeters, Marie-Jeanne T. F. D. Vrancken
    Sikorska, Karolina
    Gilhuijs, Kenneth G. A.
    [J]. BREAST CANCER RESEARCH, 2016, 18
12345